The relationship between psychological factors, inflammation, and nutrition in patients with chronic renal failure undergoing hemodialysis

International Journal of Psychiatry in Medicine

Volumn 44, Issue 2, 2012, Pages 105-118

  Wang, Liang Jen ^a,b   Wu, Mai Szu ^a,b   Hsu, Heng Jung ^a,b   Wu, I Wen ^a,b   Sun, Chiao Yin ^a,b   Chou, Chia Chi ^a,b   Lee, Chin Chan ^a,b   Tsai, Chi Ren ^a,b   Tsai, Yi Chieh ^a,b   Chen, Chih Ken ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Albumin; Cytokine; Emotion; Renal disease; Structural equation modeling

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CYTOKINE; FERRITIN; HEMOGLOBIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY FAILURE; EMOTION; FATIGUE; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NUTRITIONAL STATUS; PROTEIN BLOOD LEVEL; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE;

ADULT; AGED; ANXIETY; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; CYTOKINES; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; EMOTIONS; FEMALE; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; RENAL DIALYSIS;

EID: 84870931839     PISSN: 00912174     EISSN: 15413527     Source Type: Journal    
DOI: 10.2190/PM.44.2.b     Document Type: Article

References (50)

1. Kimmel PL. Psychosocial factors in dialysis patients. Kidney International 2001; 59: 1599-1613.
2. Drayer RA, Piraino B, Reynolds CF 3rd, Houck PR, Mazumdar S, Bernardini J, Shear MK, Rollman BL. Characteristics of depression in hemodialysis patients: Symptoms, quality of life and mortality risk. General Hospital Psychiatry 2006; 28: 306-312.
3. Chilcot J, Wellsted D, Da Silva-Gane M, Farrington K. Depression on dialysis. Nephron Clinical Practice 2008; 108:c256-c264.
4. Cukor D, Coplan J, Brown C, Peterson RA, Kimmel PL. Course of depression and anxiety diagnosis in patients treated with hemodialysis: A 16-month follow-up. Clinical Journal of the American Society of Nephrology 2008; 3: 1752-1758.
5. Jhamb M, Weisbord SD, Steel JL, Unruh M. Fatigue in patients receiving maintenance dialysis: A review of definitions, measures, and contributing factors. American Journal of Kidney Diseases 2008; 52: 353-365.
6. Kao TW, Lai MS, Tsai TJ, Jan CF, Chie WC, Chen WY. Economic, social, and psychological factors associated with health-related quality of life of chronic hemodialysis patients in northern Taiwan: A multicenter study. Artificial Organs 2009; 33: 61-68.
7. Kurella M, Kimmel PL, Young BS, Chertow GM. Suicide in the United States end-stage renal disease program. Journal of the American Society of Nephrology 2005; 16: 774-781.
8. Koo JR, Yoon JW, Kim SG, Lee YK, Oh KH, Kim GH, Kim HJ, Chae DW, Noh JW, Lee SK, Son BK. Association of depression with malnutrition in chronic hemodialysis patients. American Journal of Kidney Diseases 2003; 41: 1037-1042.
9. Dogan E, Erkoc R, Eryonucu B, Sayarlioglu H, Agargun MY. Relation between depression, some laboratory parameters, and quality of life in hemodialysis patients. Renal Failure 2005; 27: 695-699.
10. Pertosa G, Grandaliano G, Gesualdo L, Schena FP. Clinical relevance of cytokine production in hemodialysis. Kidney International Supplement 2000; 76:S104-S111.
11. Agrawal S, Gollapudi P, Elahimehr R, Pahl MV, Vaziri ND. Effects of end-stage renal disease and haemodialysis on dendritic cell subsets and basal and LPS-stimulated cytokine production. Nephrology Dialysis Transplantation 2010; 25: 737-746.
12. Capuron L, Miller AH. Immune system to brain signaling: Neuropsychopharma-cological implications. Pharmacology & Therapeutics 2011; 130: 226-238.
13. Wichers M, Maes M. The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. International Journal of Neuropsychopharmacology 2002; 5: 375-388.
14. Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress and discovery. Brain, Behavior, and Immunity 2007; 21: 374-383.
15. Miller DB, O'Callaghan JP. Depression, cytokines, and glial function. Metabolism 2005; 54: 33-38.
16. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosomatic Medicine 2009; 71: 171-186.
17. O'Donovan A, Hughes BM, Slavich GM, Lynch L, Cronin MT, O'Farrelly C, Malone KM. Clinical anxiety, cortisol and interleukin-6: Evidence for specificity in emotion-biology relationships. Brain, Behavior, and Immunity 2010; 24: 1074-1077.
18. Bossola M, Luciani G, Giungi S, Tazza L. Anorexia, fatigue, and plasma interleukin-6 levels in chronic hemodialysis patients. Renal Failure 2010; 32: 1049-1054.
19. Kim YK, Lee SW, Kim SH, Shim SH, Han SW, Choi SH, Lee BH. Differences in cytokines between non-suicidal patients and suicidal patients in major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2008; 32: 356-361.
20. Lindqvist D, Janelidze S, Hagell P, Erhardt S, Samuelsson M, Minthon L, Hansson O, Bjorkqvist M, Traskman-Bendz L, Brundin L. Interleukin-6 is elevated in the cerebro-spinal fluid of suicide attempters and related to symptom severity. Biological Psychiatry 2009; 66: 287-292.
21. Janelidze S, Mattei D, Westrin A, Traskman-Bendz L, Brundin L. Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain, Behavior, and Immunity 2011; 25: 335-339.
22. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney International 1999; 55: 1899-1911.
23. Bossola M, Luciani G, Tazza L. Fatigue and its correlates in chronic hemodialysis patients. Blood Purification 2009; 28: 245-252.
24. Huang TL, Lee CT. Low serum albumin and high ferritin levels in chronic hemo-dialysis patients with major depression. Psychiatry Research 2007; 152: 277-280.
25. Czira ME, Lindner AV, Szeifert L, Molnar MZ, Fornadi K, Kelemen A, Laszlo G, Mucsi I, Keszei AP, Kennedy SH, Novak M. Association between the Malnutrition-Inflammation Score and depressive symptoms in kidney transplanted patients. General Hospital Psychiatry 2011; 33: 157-165.
26. Chen CK, Tsai YC, Hsu HJ, Wu IW, Sun CY, Chou CC, Lee CC, Tsai CR, Wu MS, Wang LJ. Depression and suicide risk in hemodialysis patients with chronic renal failure. Psychosomatics 2010; 51: 528-528, e526.
27. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 1998; 59(Suppl 20): 22-33; quiz 34-57.
28. Kuo CJ, Tang HS, Tsay CJ, Lin SK, Hu WH, Chen CC. Prevalence of psychiatric disorders among bereaved survivors of a disastrous earthquake in Taiwan. Psychiatric Service 2003; 54: 249-251.
29. Olsson I, Mykletun A, Dahl AA. The Hospital Anxiety and Depression Rating Scale: A cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry 2005; 5:46.
30. Loosman WL, Siegert CE, Korzec A, Honig A. Validity of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory for use in end-stage renal disease patients. British Journal of Clinical Psychology 2010; 49: 507-516.
31. Leung CM, Wing YK, Kwong PK, Lo A, Shum K. Validation of the Chinese-Cantonese version of the hospital anxiety and depression scale and comparison with the Hamilton Rating Scale of Depression. Acta Psychiatrica Scandinavica 1999; 100: 456-461.
32. Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, Wallace EP. Development of a fatigue scale. Journal of Psychosomatic Research 1993; 37: 147-153.
33. Wong WS, Fielding R. Construct validity of the Chinese version of the Chalder Fatigue Scale in a Chinese community sample. Journal of Psychosomatic Research 2010; 68: 89-93.
34. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 1992; 30: 473-483.
35. Khaldoon N, Nan H. Comparative assessment of structural equation modeling and multiple regression research methodologies: E-commerce context. Tourism Management 2010; 31: 314-324.
36. Preljevic VT, Osthus TB, Sandvik L, Bringager CB, Opjordsmoen S, Nordhus IH, Os I, Dammen T. Psychiatric disorders, body mass index and C-reactive protein in dialysis patients. General Hospital Psychiatry 2011; 33: 454-461.
37. Montinaro V, Iaffaldano GP, Granata S, Porcelli P, Todarello O, Schena FP, Pertosa G. Emotional symptoms, quality of life and cytokine profile in hemodialysis patients. Clinical Nephrology 2010; 73: 36-43.
38. Sonikian M, Metaxaki P, Papavasileiou D, Boufidou F, Nikolaou C, Vlassopoulos D, Vlahakos DV. Effects of interleukin-6 on depression risk in dialysis patients. American Journal of Nephrology 2010; 31: 303-308.
39. Kalender B, Dervisoglu E, Sengul E, Ozdemir AC, Akhan SC, Yalug I, Uzun H. Depression, nutritional status, and serum cytokines in peritoneal dialysis patients: Is there a relationship? Peritoneal Dialysis International 2007; 27: 593-595.
40. Dervisoglu E, Kir HM, Kalender B, Eraldemir C, Caglayan C. Depressive symptoms and proinflammatory cytokine levels in chronic renal failure patients. Nephron Clinical Practice 2008; 108:c272-c277.
41. Blume J, Douglas SD, Evans DL. Immune suppression and immune activation in depression. Brain, Behavior, and Immunity 2011; 25: 221-229.
42. Ibrahim S, El Salamony O. Depression, quality of life and malnutrition-inflammation scores in hemodialysis patients. American Journal of Nephrology 2008; 28: 784-791.
43. Huang TL. Lower serum albumin levels in patients with mood disorders. Chang Gung Medical Journal 2002; 25: 509-513.
44. Memoli B, Minutolo R, Bisesti V, Postiglione L, Conti A, Marzano L, Capuano A, Andreucci M, Balletta MM, Guida B, Tetta C. Changes of serum albumin and C-reactive protein are related to changes of interleukin-6 release by peripheral blood mononuclear cells in hemodialysis patients treated with different membranes. American Journal of Kidney Diseases 2002; 39: 266-273.
45. Bossola M, Ciciarelli C, Di Stasio E, Conte GL, Vulpio C, Luciani G, Tazza L. Correlates of symptoms of depression and anxiety in chronic hemodialysis patients. General Hospital Psychiatry 2010; 32: 125-131.
46. Gabbay V, Klein RG, Guttman LE, Babb JS, Alonso CM, Nishawala M, Katz Y, Gaite MR, Gonzalez CJ. A preliminary study of cytokines in suicidal and non-suicidal adolescents with major depression. Journal of Child and Adolescent Psychopharmacology 2009; 19: 423-430.
47. Jhamb M, Argyropoulos C, Steel JL, Plantinga L, Wu AW, Fink NE, Powe NR, Meyer KB, Unruh ML. Correlates and outcomes of fatigue among incident dialysis patients. Clinical Journal of the American Society of Nephrology 2009; 4: 1779-1786.
48. Kalender B, Ozdemir AC, Dervisoglu E, Ozdemir O. Quality of life in chronic kidney disease: Effects of treatment modality, depression, malnutrition and inflammation. International Journal of Clinical Practice 2007; 61: 569-576.
49. Loftis JM, Huckans M, Morasco BJ. Neuroimmune mechanisms of cytokine-induced depression: Current theories and novel treatment strategies. Neurobiology of Disease 2010; 37: 519-533.
50. Lee SK, Lee HS, Lee TB, Kim DH, Koo JR, Kim YK, Son BK. The effects of antidepressant treatment on serum cytokines and nutritional status in hemodialysis patients. Journal of Korean Medical Science 2004; 19: 384-389.